Is a reduction of graft vessel disease by maximal treatment of hypercholesterolemia after heart transplantation possible?

Transplant Proc. 1995 Jun;27(3):1954-5.

Authors

K Wenke¹, B Meiser, J Thiery, N Arndtz, W von Scheidt, D Seidel, B Reichart

Affiliation

¹ Department of Cardiac Surgery, Munich-Bogenhausen, Germany.

PMID: 7792848

No abstract available

Publication types

Clinical Trial
Randomized Controlled Trial

MeSH terms

Adult
Coronary Disease / prevention & control*
Cyclosporine / blood
Female
Graft Occlusion, Vascular / prevention & control*
Graft Rejection
Heart Transplantation / adverse effects*
Humans
Hypercholesterolemia / complications
Hypercholesterolemia / therapy*
Lovastatin / analogs & derivatives
Lovastatin / therapeutic use
Male
Middle Aged
Simvastatin

Substances

Cyclosporine
Lovastatin
Simvastatin